Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P0519: Upadacitinib in Acute Severe Ulcerative Colitis among previously anti-TNFa exposed patients.ECCO'25
Year: 2025
Authors: Manti, M.(1)*;Kamperidis, N.(1);Toskas, A.(1);Misra, R.(1);Arebi, N.(1);
(1)St Mark's Hospital, Gastroenterology, London, United Kingdom;

1.Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384-413. doi:10.14309/ajg.0000000000000152
2.Berinstein JA, Karl T, Patel A, et al. Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience. Am J Gastroenterol. 2024;119(7):1421-1425. doi:10.14309/ajg.0000000000002674
3.Ali NM, Shehab MA. Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature. Am J Case Rep. 2023;24. doi:10.12659/AJCR.940966

P0520: Association between interoception and Visceral Hypervigilance in patients with Inflammatory Bowel DiseaseECCO'25
Year: 2025
Authors: Knödler, L.L.(1)*;Rösch, T.(1);Atanasova, K.(1);Ebert, M.(1);Thomann, A.(1);Reindl, W.(1);
(1)Medical Faculty Mannheim - Heidelberg University, Department of Medicine II, Mannheim, Germany;

1          Thomann AK, Knödler LL, Karthikeyan S, et al. The Interplay of Biopsychosocial Factors and Quality of Life in Inflammatory Bowel Diseases: A Network Analysis. J Clin Gastroenterol. 2023;57(1):57-65. Published 2023 Jan 1. doi:10.1097/MCG.0000000000001625

2          Herbert BM, Muth ER, Pollatos O, Herbert C. Interoception across modalities: on the relationship between cardiac awareness and the sensitivity for gastric functions. PLoS One. 2012;7(5):e36646. doi:10.1371/journal.pone.0036646

3          Whitehead WE, Drescher VM. Perception of gastric contractions and self-control of gastric motility. Psychophysiology. 1980;17(6):552-558. doi:10.1111/j.1469-8986.1980.tb02296.x

P0521: Accuracy of a non-invasive approach in monitoring pediatric inflammatory bowel disease: interim-analysis of a prospective multicenter italian studyECCO'25
Year: 2025
Authors: D'Arcangelo, G.(1)*;Gravina, A.(1);Colucci, A.(2);Raso, T.(1);Casertano, M.(2);Cenni, S.(2);Strisciuglio, C.(2);Maccioni, F.(3);Oliva, S.(1);
(1)Sapienza University of Rome, Maternal and Child Health Department, Rome, Italy;(2)University of Campania "Luigi Vanvitelli", Department of Woman- Child and General and Specialistic Surgery, Naples, Italy;(3)Sapienza University of Rome, Department of Radiological- Oncology and Patological Sciences, Rome, Italy;
P0522: Transmural healing rate does not differ between Crohn's disease patients with structural damage versus inflammatory behaviorECCO'25
Year: 2025
Authors: Marques Garcia, P.(1)*;Albert Palomares , S.(1);Fquihi Chetouani, M.(1);Torrente Sánchez, J.(1); Pérez Ibáñez, A.A.(1);Rabadán Mata, A.(1);Peiró García, E.(1);Blanc Garcia, E.(2);Martinez Perez, M.J.(2);Paredes Arquiola, J.M.(1);
(1)Hospital Doctor Peset, Department of Digestive Medicine, Valencia, Spain;(2)Hospital Doctor Peset, Department of Diagnostic Radiology, Valencia, Spain; Transmural healing rate does not differ between crohn's disease patients with structural damage versus inflammatory behavior

1.Wilkens R, Novak KL, Maaser C, et al. Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives. TherapAdvGastroenterol. 2021. doi: 10.1177/17562848211006672.
2.Paredes JM, Moreno N, Latorre P, et al. Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease. Dig Dis Sci. 2019;64:2600-2606. 
3.Muñoz F, Ripollés T, Poza Cordón J, et al. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease. GastroenterolHepatol. 2021;44:158-174. 
4.Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study. ClinGastroenterolHepatol. 2022;20:711-722. 
5.Fraquelli M, Castiglione F, Calabrese E, et al. Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice. Dig Liver Dis. 2020;52:9-18.
6.Fiorino G, Bonifacio C, Allocca M, et al. Impact of therapies on bowel damage in Crohn's disease. United European Gastroenterol J. 2020;8:410-417.

P0523: Comparative analysis of two ELISA methods for measuring serum ustekinumab levels in Inflammatory Bowel Disease ¿Is interchangeability feasible?ECCO'25
Year: 2025
Authors: Dueñas-Prieto, L.(1);Cabrera-Marante, Ó.(1);Algara, M.(2);Alfocea-Molina, Á.(1);Rafael de la Cruz, D.(2);Garcinuño, S.(3);Masedo, Á.(2);Yela, C.(2);López, F.(2);Olmedo, C.(2);Casis, B.(2);Gonzalez LamaMD- PhD, Y.(2)*;
(1)Hospital Universitario 12 de Octubre, Immunology Department, Madrid, Spain;(2)Hospital Universitario 12 de Octubre, Digestive Medicine Department. Gastroenterology Section. IBD Unit., Madrid, Spain;(3)Hospital Universitario 12 de Octubre, Research Institute imas12, Madrid, Spain;

- Kwon Y, Kang B, Kim ES, Choe YH, Kim MJ. Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease. Ther Drug Monit. 2022;44(4):535-542. doi:10.1097/FTD.0000000000000976 

- Rodríguez-Moranta F, Argüelles-Arias F, Hinojosa Del Val J, et al. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU). Gastroenterol Hepatol. 2024;47(5):522-552. doi:10.1016/j.gastrohep.2024.01.007

P0524: Advanced therapy options, choice, access, and treatment empowerment for Inflammatory Bowel Disease (ADVOCATE-IBD): A UK-wide qualitative studyECCO'25
Year: 2025
Authors: Hardasani, R.(1)*;Radford, S.(2);Peerally, M.(3);
(1)University of Leicester, Medical School, Leicester, United Kingdom;(2)The University of Nottingham- School of Medicine, Nottingham NIHR Biomedical Research Centre- Liver and GI Disorders, Nottingham, United Kingdom;(3)University of Leicester, Department of Population Health Sciences- SAPPHIRE, Leicester, United Kingdom;

1. Jairath V, Feagan BG. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2020;5(1):2–3. Accessed Apr 15, 2024. doi: 10.1016/S2468-1253(19)30358-9.

2. Lofland JH, Johnson PT, Ingham MP, Rosemas SC, White JC, Ellis L. Shared decision-making for biologic treatment of autoimmune disease: Influence on adherence, persistence, satisfaction, and health care costs. Patient Preference and Adherence. 2017;11:947–958. https://www.tandfonline.com/doi/abs/10.2147/PPA.S133222. Accessed Dec 31, 2023. doi: 10.2147/PPA.S133222.

3. Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022;292:114523. Accessed Nov 5, 2023. doi: 10.1016/j.socscimed.2021.114523.

4. Green J, Thorogood N. Qualitative methods for health research / judith green, nickithorogood. 4th ed. London: SAGE Publications Ltd; 2018:17. http://digital.casalini.it/9781526448804.

P0525: Genome-wild gene expression analysis and identification of Crohn's disease from intestinal tuberculosis and primary intestinal lymphomaECCO'25
Year: 2025
Authors: Lin, L.(1);Wang, Y.(1)*;Zhao, X.(1);
(1)Nanfang Hospital- Southern Medical University, Department of Gastroenterology, Guangzhou, China;

[1]TORRES J, MEHANDRU S, COLOMBEL J F, et al. Crohn's disease [J]. Lancet (London, England), 2017, 389(10080): 1741-55.
[2]PEREZ E J, CEPERO M L, PEREZ S U, et al. EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain [J]. Neurobiology of disease, 2016, 94: 73-84.
[3]THEUS M H, RICARD J, GLASS S J, et al. EphrinB3 blocks EphB3 dependence receptor functions to prevent cell death following traumatic brain injury [J]. Cell death & disease, 2014, 5(5): e1207.
[4]CHIU S T, CHANG K J, TING C H, et al. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells [J]. Carcinogenesis, 2009, 30(9): 1475-86.

P0526: Association of plasma IgA with bowel wall thickness and disease activity in IBD patients assessed by intestinal ultrasoundECCO'25
Year: 2025
Authors: Chen, Y.L.(1)*;Tsai, T.(1,2,3);
(1)China Medical University Hospital, Center for Digestive Medicine, Taichung, Taiwan;(2)National Health Research Institutes, Immunology Research Center, Zhunan, Taiwan;(3)China Medical University, School of Medicine, Taichung, Taiwan;

1. B Lee, J Hsu, T Tsai, A241 Correlation between plasma IgA level and biological therapy in inflammatory bowel disease, Journal of the Canadian Association of Gastroenterology, 2024;doi.org/10.1093/jcag/gwad061.241

P0527: Bowel Ultrasound Scan (BUS) in Pediatric Acute Severe Colitis (ASC): a multicenter prospective study on behalf of the IBD Porto groupECCO'25
Year: 2025
Authors: Scarallo, L.(1)*;Alvisi, P.(2);Aloi, M.(3);Bramuzzo, M.(4);Broekaert, I.(5);De Laffolie, J.(6);Kierkus, J.(7);Matar, M.(8);Pranzetti, A.(9);Renzo, S.(1);Velasco Rodríguez-Belvís, M.(10);Strisciuglio, C.(11);Tasciotti, L.(12);Lionetti, P.(1);
(1)Meyer Children's Hospital IRCCS, Gastroenterology and Nutrition Unit, Florence, Italy;(2)Maggiore "CA Pizzardi" Hospital- Bologna- Italy, Pediatric Gastroenterology Unit-, Bologna, Italy;(3)Sapienza University of Rome- Umberto I Hospital- Rome- Italy., Pediatric Gastroenterology and Hepatology Unit-, Rome, Italy;(4)IRCCS "Burlo Garofolo", Institute for Maternal and Child Health, Trieste, Italy;(5)Faculty of Medicine and University Hospital Cologne- University of Cologne- Cologne- Germany, Department of Paediatrics, Cologne, Germany;(6)Justus-Liebig-University Giessen- Childrens Hospital, Pediatric Gastroenterology, Giessen, Italy;(7)The Children's Memorial Health Institute- 04-730 Warsaw- Poland, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics-, Warsaw, Poland;(8)Schneider Children's Medical Centre- Petach-Tikva- Israel, Institute of Gastroenterology- Nutrition and Liver Diseases, Petach-Tikva, Israel;(9)Maggiore "CA Pizzardi" Hospital- Bologna- Italy., Pediatric Gastroenterology Unit, Bologna, Italy;(10)Hospital Infantil Universitario Niño Jesús- Madrid- Spain, Sección de Gastroenterología y Nutrición Pediátrica-, Madrid, Spain;(11)University of Campania "Luigi Vanvitelli"- Naples- Italy, Department of Woman- Child and General and Specialist Surgery, Naples, Italy;(12)Meyer Children's Hospital IRCCS, Radiology Unit, Florence, Italy; IBD Porto Group
P0528: Leukocyte Adhesive Function as Potential Predictive Marker for Treatment Response to Vedolizumab Among Bio-naive Patients with Crohn’s DiseaseECCO'25
Year: 2025
Authors: Liu, J.(1,2)*;Cheng, Q.(3);Cao, Q.(1,2);
(1)Sir Run Run Shaw Hospital- Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China;(2)Sir Run Run Shaw Hospital- Zhejiang University School of Medicine, Inflammatory Bowel Disease Center, Hangzhou, China;(3)StickyCell Biotech Shanghai Ltd, StickyCell Biotech Shanghai Ltd, Shanghai, China;

Dulai PS, Boland BS, Singh S, et al. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease. Gastroenterology. 2018;155(3):687-695.e10. doi:10.1053/j.gastro.2018.05.039

P0530: Relationships and sexuality in patients with inflammatory bowel disease – The perspective of healthcare professionalsECCO'25
Year: 2025
Authors: Jäghult, S.(1)*;Druvefors, E.(2);Bello, F.(3);Florwald, E.(4);Forsell, A.(5);Myrelid, P.(6);Almer, S.(3);
(1)Karolinska Institutet, Department of clinical science and education, Stockholm, Sweden;(2)Länssjukhuset Ryhov, Länssjukhuset Ryhov, Jönköping, Sweden;(3)Karolinska Institutet, Karolinska Institutet, Stockholm, Sweden;(4)Karolinska Institutet, Ersta sjukhus, Stockholm, Sweden;(5)Ersta Hospital, Ersta Hospital, Stockholm, Sweden;(6)Linköping University Hospital, Linköping University Hospital, Linköpig, Sweden;
P0532: Exploring biomarkers of systemic oxidative stress and placental insufficiency in pregnant women with Inflammatory Bowel DiseaseECCO'25
Year: 2025
Authors: Holstein, H.J.(1);Bouwknegt, D.G.(1);Visschedijk, M.C.(1);Bulthuis, M.L.C.(2);Reinders-Luinge, M.(2);Schoots, M.H.(3);van Goor, H.(2);Gordijn, S.J.(3);Dijkstra, G.(1);Bourgonje, A.R.(1,4)*;
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands;(3)University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands;(4)Icahn School of Medicine at Mount Sinai, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;
P0533: Extremely Rare Case of Isolated Colonic Inflammatory Cap Polyps in a Patient with Known Long-Standing Ulcerative ColitisECCO'25
Year: 2025
Authors: Pellegrino, R.(1);Palladino, G.(1);De Costanzo, I.(1);Izzo, M.(1);Imperio, G.(1);Landa, F.(1);Federico, A.(1);Gravina, A.G.(1)*;
(1)University of Campania Luigi Vanvitelli, Department of Precision Medicine, Naples, Italy;

Mason M, Faizi SA, Fischer E, Rajput A. Inflammatory cap polyposis in a 42-year-old male. Int J Surg Case Rep. 2013;4(3):351-353. doi:10.1016/j.ijscr.2012.12.0142. 
Batra S, Johal J, Lee P, Hourigan S. Cap Polyposis Masquerading as Inflammatory Bowel Disease in a Child. J Pediatr Gastroenterol Nutr. 2018;67(3):e57. doi:10.1097/MPG.00000000000013433.  Valdés Delgado T, Barranco Castro D,
Argüelles Arias F. Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis. Inflamm Bowel Dis. 2022;28(7):e108-e109. doi:10.1093/ibd/izac023

P0534: School-related challenges in paediatric Inflammatory Bowel Diseases and the role of patient associations: results from a national survey of over 350 italian paediatric patientsECCO'25
Year: 2025
Authors: Gianolio, L.(1)*;Silvera, V.(1);Quaglia, M.(2);Brazzoduro, V.(2);Penagini, F.(2);Dilillo, D.(2);Previtali, E.(3);Leone, S.(3);Zuccotti, G.V.(1,4);Norsa, L.(2);
(1)Buzzi Children's Hospital University of Milan, Department of Paediatrics, Milan, Italy;(2)Buzzi Children's Hospital, Department of Paediatrics, Milan, Italy;(3)AMICI Italia Onlus, Associazione Nazionale per le Malattie Infiammatorie Croniche dell’Intestino, Milan, Italy;(4)University of Milan, Department of Biomedical and Clinical Sciences, Milan, Italy;

1.Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. doi:10.1053/j.gastro.2020.12.031
2. Freckmann M, Seipp A, Laass MW, et al. School-related experience and performance with inflammatory bowel disease: results from a cross-sectional survey in 675 children and their parents. BMJ Open Gastroenterol. 2018;5(1):e000236. doi:10.1136/bmjgast-2018-000236

P0535: Crohn’s Anal Fistula - Quality of Life (CAFQOL) for disease control and remission in patients with perianal fistulizing Crohn’s disease: a new standard in assessing clinical outcome?ECCO'25
Year: 2025
Authors: Mulders, L.(1)*;Beek, K.(2);Tielbeek, J.(3);Zwart, M.(1);Rietdijk, S.(4);Jansen, J.(4);Stoker, J.(2);Buskens, C.(5);D'Haens, G.(1);Gecse, K.(1);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC, Department of Radiology and Nuclear Medicine, Amsterdam, The Netherlands;(3)Spaarne Gasthuis, Department of Radiology and Nuclear Medicine, Haarlem, The Netherlands;(4)OLVG, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(5)Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands; AMFIBIO study group
P0536: Clinical profile and treatment outcomes in patients receiving advanced therapies for ulcerative colitis – the READ-UC real-world studyECCO'25
Year: 2025
Authors: Fernandes, S.R.(1)*;Tavares de Sousa, H.(2);Portela, F.(3);Ministro, P.(4);Lago, P.(5);Branquinho, D.(6);Freitas, I.(7);Martins Machado, N.(7);Magro, F.(8);
(1)Unidade Local de Saúde de Santa Maria, Serviço de Gastrenterologia e Hepatologia, Lisbon, Portugal;(2)Unidade Local de Saúde do Algarve, Serviço de Gastrenterologia, Portimão, Portugal;(3)Unidade Local de Saúde de Coimbra, Serviço de Gastrenterologia, Coimbra, Portugal;(4)Unidade Local de Saúde de Viseu Dão-Lafões, Serviço de Gastrenterologia, Viseu, Portugal;(5)Unidade Local de Saúde de Santo António, Serviço de Gastrenterologia, Porto, Portugal;(6)Pfizer Inc, Medical Affairs, New York, United States;(7)Laboratórios Pfizer Lda, Medical Affairs, Porto Salvo, Portugal;(8)Unidade Local de Saúde de São João, Serviço de Gastrenterologia, Porto, Portugal;
P0537: Prognostic significance of anastomotic lesions in post-operative Crohn's diseaseECCO'25
Year: 2025
Authors: Del Gaudio, A.(1)*;Cuccia, G.(1);Privitera, G.(2);Parisio , L.(3);Coppola, G.(3);Laterza, L.(3);Lopetuso, L.R.(3);Carbone, L.(4);Papa, A.(1);Cammarota, G.(1);Gasbarrini, A.(1);Scaldaferri, F.(3);Pugliese, D.(5);
(1)Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica, Roma, Italy;(2)Humanitas University, UOS Malattie Infiammatorie Croniche Intestinali, Milano, Italy;(3)Fondazione Policlinico Universitario "A. Gemelli" IRCCS, UOS Malattie Infiammatorie Croniche Intestinali - Centro Malattie Apparato Digerente CEMAD, Roma, Italy;(4)Ospedale Isola Tiberina Gemelli Isola, UOC Pronto Soccorso- Medicina d'Urgenza e Medicina Interna, Roma, Italy;(5)Ospedale Isola Tiberina Gemelli Isola, UOS Gastroenterologia, Roma, Italy;

  1. 1)     De Cruz P, Hamilton AL, Burrell KJ, Gorelik A, Liew D, Kamm MA. Endoscopic Prediction of Crohn's Disease Postoperative Recurrence. Inflamm Bowel Dis. 2022 May 4;28(5):680-688. doi: 10.1093/ibd/izab134. PMID: 34231852.2)     
    2)    Ueda T, Koyama F, Sugita A, Ikeuchi H, Futami K, Fukushima K, Nezu R, Iijima H, Mizushima T, Itabashi M, Watanabe K, Hata K, Shinagawa T, Matsuoka K, Takenaka K, Sasaki M, Nagayama M, Yamamoto H, Shinozaki M, Fujiya M, Kato J, Ueno Y, Tanaka S, Okita Y, Hashimoto Y, Kobayashi T, Koganei K, Uchino M, Fujii H, Suzuki Y, Hisamatsu T. Endoscopic Lesions of Postoperative Anastomotic Area in Patients With Crohn's Disease in the Biologic Era: A Japanese Multi-Centre Nationwide Cohort Study. J Crohns Colitis. 2023 Dec 30;17(12):1968-1979. doi: 10.1093/ecco-jcc/jjad116. PMID: 37450892.
P0538: Histologic remission predicts relapse in patients with Ulcerative ColitisECCO'25
Year: 2025
Authors: Lopes, S.(1)*;Teixeira, M.(1);Tomás, D.(1);Sequeira, C.(1);Teixeira, C.(1);Gamito, É.(1);Alves, A.L.(1);
(1)Unidade Local Saúde Arrábida, Gastroenterology, Setúbal, Portugal;

Lobatón T, Bessissow T, Ruiz-Cerulla A, De Hertogh G, Bisschops R, Guardiola J, Van Assche G, Vermeire S, Ferrante M. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study. United European Gastroenterol J. 2018 Jun;6(5):765-772. doi: 10.1177/2050640617752207. 

P0539: Prevalence of QuantiFERON Positivity in Patients with Inflammatory Bowel Disease Eligible for Biological Therapy: Clinical and Demographic AnalysisECCO'25
Year: 2025
Authors: Guinea Lagunes , A.(1)*;Philippe Ponce, M.(1);Contreras Aviles, E.(1);Almeida del Prado, G.(1);López Perez, R.(1);Esquivel Steffanoni, M.(1);Jiménez Bobadilla, B.(2);De Leon Rendon, J.L.(3);
(1)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Inflammatory Bowel Disease Clinic, Ciudad de México, Mexico;(2)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Coloproctology Service, Ciudad de México, Mexico;(3)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Inflammatory Bowel Disease Clinic, Mexico, Mexico;

Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI. Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization. Inflamm Bowel Dis. 2017 Dec 19;24(1):217-226. doi: 10.1093/ibd/izx019. PMID: 29272482; PMCID: PMC7007987. Lai HC, Chang CH, Cheng KS, Chen TW, Tsai YY, Chou JW. QuantiFERON-TB Gold Test Conversion Is Associated with Active Tuberculosis Development in Inflammatory Bowel Disease Patients Treated with Biological Agents: An Experience of a Medical Center in Taiwan. Gastroenterol Res Pract. 2019 Nov 3;2019:7132875. doi: 10.1155/2019/7132875. PMID: 31781198; PMCID: PMC6875270. Calzada-Hernández J, Anton-López J, Bou-Torrent R, Iglesias-Jiménez E, Ricart-Campos S, Martín de Carpi J; Carmen García de Vicuña Muñoz de la Nava; Torrente-Segarra V, Sánchez-Manubens J, Giménez-Roca C, Rozas-Quesada L, Juncosa-Morros MT, Fortuny C, Noguera-Julian A. Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study. Pediatr Rheumatol Online J. 2015 Dec 3;13:54. doi: 10.1186/s12969-015-0054-4. PMID: 26635208; PMCID: PMC4669612. Calzada-Hernández J, Anton J, Martín de Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny C, Tebruegge M, Noguera-Julian A. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain. Eur J Pediatr. 2023 Jan;182(1):307-317. doi: 10.1007/s00431-022-04640-3. Epub 2022 Nov 5. PMID: 36335186; PMCID: PMC9829583.

P0540: Assessment of Metabolic-Associated Liver Disease in Patients with Crohn's Disease in Long-Term RemissionECCO'25
Year: 2025
Authors: Amiama Roig, C.(1)*;Cristina, S.F.(2,3);Laura, G.R.(2,3);Jose Luis, R.G.(2,3);Maria, S.A.(2,3);Eduardo, M.A.(2,3);Joaquin, P.C.(2,3);Irene, G.D.(1);Carmen, A.C.(1);Maria Dolores, M.A.(2,3,4);
(1)La Paz University Hospital, Gastroenterology Department, Madrid, Spain;(2)La Paz University Hospital, Inflammatory Bowel Disease Unit- Gastroenterology Department, Madrid, Spain;(3)La Paz University Hospital Research Institute – IdiPAZ, La Paz University Hospital Research Institute – IdiPAZ, Madrid, Spain;(4)Autonomous University of Madrid, Medical School, Madrid, Spain;